| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.426 | 11.604 | 15.256 | 10.274 | 12.797 | 17.609 |
| Total Income - EUR | - | - | - | - | 11.148 | 29.362 | 17.302 | 11.841 | 13.625 | 18.646 |
| Total Expenses - EUR | - | - | - | - | 10.754 | 29.361 | 17.046 | 11.609 | 13.420 | 15.682 |
| Gross Profit/Loss - EUR | - | - | - | - | 394 | 0 | 256 | 232 | 205 | 2.965 |
| Net Profit/Loss - EUR | - | - | - | - | 370 | -72 | 116 | 3 | 90 | 2.511 |
| Employees | - | - | - | - | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Terapii Prietenoase S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 640 | 6.229 | 3.468 | 1.773 | 1.044 | 2.666 |
| Current Assets | - | - | - | - | 25.354 | 765 | 854 | 961 | 1.258 | 1.407 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 9.564 | 0 | 107 | 88 | 133 | 0 |
| Cash | - | - | - | - | 15.790 | 765 | 748 | 872 | 1.125 | 1.407 |
| Shareholders Funds | - | - | - | - | 412 | 333 | 441 | 446 | 534 | 3.041 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.770 | 1.057 | 448 | 411 | 724 | 1.032 |
| Income in Advance | - | - | - | - | 23.812 | 5.604 | 3.434 | 1.877 | 1.044 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Terapii Prietenoase S.r.l.